174 related articles for article (PubMed ID: 12866960)
41. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms.
Hall PA; Levison DA; Woods AL; Yu CC; Kellock DB; Watkins JA; Barnes DM; Gillett CE; Camplejohn R; Dover R
J Pathol; 1990 Dec; 162(4):285-94. PubMed ID: 1981239
[TBL] [Abstract][Full Text] [Related]
42. Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer.
Kamai T; Takagi K; Asami H; Ito Y; Oshima H; Yoshida KI
Br J Cancer; 2001 May; 84(9):1242-51. PubMed ID: 11336477
[TBL] [Abstract][Full Text] [Related]
43. [Expression of DPC4/Smad4, p21wafI, and p16 in human pancreatic cancer].
Gu LJ; Chen J; Lu ZH; Li L; Zhou WX; Luo YF
Ai Zheng; 2002 Feb; 21(2):132-7. PubMed ID: 12479060
[TBL] [Abstract][Full Text] [Related]
44. Human p57(KIP2) defines a new imprinted domain on chromosome 11p but is not a tumour suppressor gene in Wilms tumour.
Taniguchi T; Okamoto K; Reeve AE
Oncogene; 1997 Mar; 14(10):1201-6. PubMed ID: 9121769
[TBL] [Abstract][Full Text] [Related]
45. [Expressions of p53 and Gadd45a proteins in human pancreatic cancer and their clinicopathological significance].
Dong M; Zhou JP; Kong FM; Guo KJ; Tian YL; Dong YT
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):628-32. PubMed ID: 16274047
[TBL] [Abstract][Full Text] [Related]
46. Regulation of p57(KIP2) during muscle differentiation: role of Egr1, Sp1 and DNA hypomethylation.
Figliola R; Busanello A; Vaccarello G; Maione R
J Mol Biol; 2008 Jul; 380(2):265-77. PubMed ID: 18513743
[TBL] [Abstract][Full Text] [Related]
47. [Expression of P27 protein and cyclin E in colon cancer].
Dai JY; Liang XP; Wen JL; Li CY; Deng CZ; Zhang ZH
Ai Zheng; 2003 Oct; 22(10):1093-5. PubMed ID: 14558959
[TBL] [Abstract][Full Text] [Related]
48. Expression of p57/Kip2 protein in pancreatic adenocarcinoma.
Ito Y; Takeda T; Wakasa K; Tsujimoto M; Matsuura N
Pancreas; 2001 Oct; 23(3):246-50. PubMed ID: 11590319
[TBL] [Abstract][Full Text] [Related]
49. [Expression of nm23 and proliferating cell nuclear antigen (PCNA) in human brain gliomas and their significance].
Tan PG; Li ZQ; Cai WQ; Lu JP; Xie FS; Weng Y
Ai Zheng; 2003 Oct; 22(10):1077-80. PubMed ID: 14558955
[TBL] [Abstract][Full Text] [Related]
50. Downregulation of p57kip² promotes cell invasion via LIMK/cofilin pathway in human nasopharyngeal carcinoma cells.
Chow SE; Wang JS; Lin MR; Lee CL
J Cell Biochem; 2011 Nov; 112(11):3459-68. PubMed ID: 21769918
[TBL] [Abstract][Full Text] [Related]
51. P21-activated kinase 4 regulates the cyclin-dependent kinase inhibitor p57(kip2) in human breast cancer.
Li Y; Wang D; Zhang H; Wang C; Dai W; Cheng Z; Wang G; Li F
Anat Rec (Hoboken); 2013 Oct; 296(10):1561-7. PubMed ID: 23873832
[TBL] [Abstract][Full Text] [Related]
52. The cyclin kinase inhibitor p57kip2 regulates TGF-beta-induced compensatory tubular hypertrophy: effect of the immunomodulator AS101.
Sinuani I; Weissgarten J; Beberashvili I; Rapoport MJ; Sandbank J; Feldman L; Albeck M; Averbukh Z; Sredni B
Nephrol Dial Transplant; 2009 Aug; 24(8):2328-38. PubMed ID: 19321762
[TBL] [Abstract][Full Text] [Related]
53. [Relationship between the expression of beta-cat, cyclin D1 and c-myc and the occurance and biological behavior of pancreatic cancer].
Li YJ; Ji XR
Zhonghua Bing Li Xue Za Zhi; 2003 Jun; 32(3):238-41. PubMed ID: 12882690
[TBL] [Abstract][Full Text] [Related]
54. Significance of p57(Kip2) down-regulation in oncogenesis of bladder carcinoma: an immunohistochemical study.
Bozdoğan O; Atasoy P; Batislam E; Başar MM; Başar H
Tumori; 2008; 94(4):556-62. PubMed ID: 18822693
[TBL] [Abstract][Full Text] [Related]
55. [Expression and significance of P57(kip2) and Maspin in pathological scar].
Cai YM; Zhu SZ; Zheng ZF; Yang WQ; Wu WY
Zhonghua Zheng Xing Wai Ke Za Zhi; 2011 Nov; 27(6):431-6. PubMed ID: 22292406
[TBL] [Abstract][Full Text] [Related]
56. A study of the expression of Cyclin E and its isoforms in tumor and adjacent mucosa, correlated to patient outcome in early colon cancer.
Corin I; Larsson L; Bergström J; Gustavsson B; Derwinger K
Acta Oncol; 2010; 49(1):63-9. PubMed ID: 20001501
[TBL] [Abstract][Full Text] [Related]
57. p57(Kip2) and cancer: time for a critical appraisal.
Borriello A; Caldarelli I; Bencivenga D; Criscuolo M; Cucciolla V; Tramontano A; Oliva A; Perrotta S; Della Ragione F
Mol Cancer Res; 2011 Oct; 9(10):1269-84. PubMed ID: 21816904
[TBL] [Abstract][Full Text] [Related]
58. Simultaneous detection of imprinted gene expression (p57(KIP2)) and molecular cytogenetics (FICTION) in the evaluation of molar pregnancies.
Hoffner L; Parks WT; Swerdlow SH; Carson JC; Surti U
J Reprod Med; 2010; 55(5-6):219-28. PubMed ID: 20626178
[TBL] [Abstract][Full Text] [Related]
59. The multiple roles of the cyclin-dependent kinase inhibitory protein p57(KIP2) in cerebral cortical neurogenesis.
Tury A; Mairet-Coello G; DiCicco-Bloom E
Dev Neurobiol; 2012 Jun; 72(6):821-42. PubMed ID: 22076965
[TBL] [Abstract][Full Text] [Related]
60. Clinical significance of nucleostemin and proliferating cell nuclear antigen protein expression in non-small cell lung cancer.
Li X; Liu X; Cui D; Wu X; Qian R
J BUON; 2015; 20(4):1088-93. PubMed ID: 26416061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
